BioCentury
ARTICLE | Company News

Celebrex approved for ankylosing spondylitis

July 29, 2005 11:35 PM UTC

FDA approved an sNDA for Celebrex celecoxib from Pfizer (PFE) to relieve the signs and symptoms of ankylosing spondylitis. The COX-2 inhibitor is approved in the U.S. to treat osteoarthritis, rheumato...